[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Connect Biopharma Holdings Ltd ADR (CNTB)

Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 125,298
  • Shares Outstanding, K 62,964
  • Annual Sales, $ 60 K
  • Annual Income, $ -55,480 K
  • EBIT $ -66 M
  • EBITDA $ -66 M
  • 60-Month Beta -0.22
  • Price/Sales 1,967.62
  • Price/Cash Flow N/A
  • Price/Book 2.65

Options Overview Details

View History
  • Implied Volatility 433.79% (+15.49%)
  • Historical Volatility 75.24%
  • IV Percentile 89%
  • IV Rank 29.65%
  • IV High 1,428.10% on 09/09/25
  • IV Low 14.66% on 03/17/26
  • Expected Move (DTE 23) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 73
  • Volume Avg (30-Day) 170
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 3,626
  • Open Int (30-Day) 4,698
  • Expected Range 2.0900 to 2.0900

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.31
  • Number of Estimates 2
  • High Estimate $-0.31
  • Low Estimate $-0.32
  • Prior Year $-0.23
  • Growth Rate Est. (year over year) -34.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.9200 +8.85%
on 06/23/26
2.7200 -23.16%
on 05/26/26
-0.2600 (-11.06%)
since 05/22/26
3-Month
1.9200 +8.85%
on 06/23/26
3.8200 -45.29%
on 03/27/26
-0.8600 (-29.15%)
since 03/23/26
52-Week
0.9100 +129.67%
on 06/24/25
3.8200 -45.29%
on 03/27/26
+1.1100 (+114.36%)
since 06/23/25

Most Recent Stories

More News
Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026

Connect Biopharma (NASDAQ:CNTB) Chief Executive Officer Barry Quart said the company’s rademikibart program continues to show a differentiated clinical and mechanistic profile as the company awaits mid-2026...

CNTB : 2.0900 (+5.03%)
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms

ORLANDO, FL / ACCESS Newswire / April 7, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming virtual...

CLDI : 0.1560 (-2.50%)
INAB : 1.4600 (unch)
CNTB : 2.0900 (+5.03%)
DMAC : 6.28 (+6.62%)
NSRX : 3.30 (+5.77%)
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Small...

CNTB : 2.0900 (+5.03%)
BESS : 4.98 (-15.31%)
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3

ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company),...

CNTB : 2.0900 (+5.03%)
Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / April 11, 2025 / RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on the...

BFRG : 0.6624 (+0.35%)
CNTB : 2.0900 (+5.03%)
Stocks Set To Open Lower As Investors Await Fed Meeting, Banking Sector Remains In Focus

June S&P 500 futures (ESM23) are down -0.13%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.10% this morning after three major U.S. benchmark indices closed in the red on Friday as ongoing concerns...

MARA : 14.70 (-1.01%)
CS : 0.8858 (+0.99%)
ESM23 : 4,453.35s (+0.61%)
HUT : 120.51 (-0.44%)
FRC : 3.51 (-43.30%)
CNTB : 2.0900 (+5.03%)
UBS : 50.29 (-1.66%)
PLD : 145.25 (+0.99%)
NQM23 : 15,316.61s (+0.85%)
RIOT : 28.69 (+0.21%)
Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases,...

CNTB : 2.0900 (+5.03%)
Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases,...

CNTB : 2.0900 (+5.03%)
Connect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual Meeting

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases,...

CNTB : 2.0900 (+5.03%)
Connect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022

— Connect to Evaluate Efficacy and Safety Data on 255 Patients Already Enrolled — — Expected Timing for Potential NDA Approval in China Remains...

CNTB : 2.0900 (+5.03%)

Business Summary

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from our T cell-driven research. The company's product candidate includes CBP-201. Connect...

See More

Key Turning Points

3rd Resistance Point 2.3600
2nd Resistance Point 2.2400
1st Resistance Point 2.1600
Last Price 2.0900
1st Support Level 1.9700
2nd Support Level 1.8500
3rd Support Level 1.7700

See More

52-Week High 3.8200
Fibonacci 61.8% 2.7100
Fibonacci 50% 2.3700
Last Price 2.0900
Fibonacci 38.2% 2.0200
52-Week Low 0.9100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.